X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (445) 445
Publication (43) 43
Book Review (15) 15
Conference Proceeding (13) 13
Newspaper Article (7) 7
Book Chapter (6) 6
Paper (4) 4
Book / eBook (3) 3
Magazine Article (1) 1
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (127) 127
humans (116) 116
female (81) 81
hematology (80) 80
male (75) 75
adult (72) 72
adolescent (60) 60
middle aged (58) 58
child (48) 48
bone marrow transplantation (43) 43
aged (37) 37
child, preschool (36) 36
transplantation (35) 35
analysis (30) 30
medicine, research & experimental (29) 29
transplante de medula óssea (28) 28
young adult (27) 27
treatment outcome (26) 26
neurosciences (25) 25
immunology (24) 24
oncology (24) 24
abridged index medicus (23) 23
chemistry, analytical (22) 22
fanconi anemia (21) 21
hemic and lymphatic diseases (21) 21
retrospective studies (20) 20
chronic myeloid leukemia (19) 19
imatinib mesylate (18) 18
psychiatry (18) 18
risk factors (18) 18
aged, 80 and over (17) 17
diseases of the blood and blood-forming organs (17) 17
hematopoietic stem cell transplantation (17) 17
hematology, oncology and palliative medicine (16) 16
spectroscopy (16) 16
research (15) 15
bone marrow (14) 14
bone-marrow-transplantation (14) 14
follow-up studies (14) 14
hematopoietic stem cells (14) 14
surgery (14) 14
therapy (14) 14
astrophysics (13) 13
brazil (13) 13
cancer (13) 13
chemometrics (13) 13
chronic myelogenous leukemia (13) 13
classification (13) 13
disease-free survival (13) 13
case-control studies (12) 12
cyclophosphamide (12) 12
fanconi's anemia (12) 12
follow-up (12) 12
infant (12) 12
pathology (12) 12
survival (12) 12
survival analysis (12) 12
versus-host-disease (12) 12
antineoplastic agents - therapeutic use (11) 11
astronomy & astrophysics (11) 11
dasatinib (11) 11
genetics & heredity (11) 11
leukemia (11) 11
original (11) 11
risk (11) 11
stem cells (11) 11
stem-cell transplantation (11) 11
surgical procedures, operative (11) 11
animals (10) 10
care and treatment (10) 10
fanconi anemia - therapy (10) 10
forestry (10) 10
graft-versus-host disease (10) 10
medicine, general & internal (10) 10
neurosciences. biological psychiatry. neuropsychiatry (10) 10
benzamides (9) 9
biochemistry & molecular biology (9) 9
brazil - epidemiology (9) 9
kaplan-meier estimate (9) 9
management (9) 9
protein kinase inhibitors - therapeutic use (9) 9
pyrimidines - therapeutic use (9) 9
cells (8) 8
cosmology and extragalactic astrophysics (8) 8
diagnosis (8) 8
endoscopic (8) 8
endoscopy - methods (8) 8
galaxy astrophysics (8) 8
graft vs host disease (8) 8
incidence (8) 8
medical research (8) 8
otorhinolaryngology (8) 8
physics - astrophysics of galaxies (8) 8
pyrimidines - adverse effects (8) 8
risk-factors (8) 8
solar and stellar astrophysics (8) 8
spectra (8) 8
survival rate (8) 8
transplantation, homologous (8) 8
usage (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2251 - 2259
The treatment of chronic myeloid leukemia (CML) achieved a great leap forward with the development of imatinib, a BCR-ABL kinase inhibitor. Alterations in the... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | PHASE CML-CP | MOLECULAR RESPONSES | UP SUSTAINED SURVIVAL | 800 MG | HARMONIZING CURRENT METHODOLOGY | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | PATIENTS PTS | BCR-ABL TRANSCRIPTS | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Blast Crisis - prevention & control | Protein Kinase Inhibitors - adverse effects | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Kaplan-Meier Estimate | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Adolescent | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - adverse effects | Aged | Benzamides | Nilotinib | Antiviral agents | Safety and security measures | Chronic myeloid leukemia | Drug therapy | Comparative analysis | Clinical trials | Drug dosages | Medical treatment | Index Medicus | Abridged Index Medicus | bcr-abl | pathology | Leukemia | Chronic-Phase | Myeloid | Klinisk medicin | 80 and over | Pyrimidines | administration & dosage | Fusion Proteins | Blast Crisis | drug therapy | Piperazines | Antineoplastic Agents | prevention & control | antagonists & inhibitors | Clinical Medicine | Protein Kinase Inhibitors | adverse effects | therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 24, pp. 2260 - 2270
Journal Article
Journal Article
Journal Article
AMERICAN JOURNAL OF HEMATOLOGY, ISSN 0361-8609, 07/2014, Volume 89, Issue 7, pp. 732 - 742
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2011, Volume 118, Issue 17, pp. 4567 - 4576
Journal Article
by Experts in Chronic Myeloid Leukemia, in Chronic Myeloid Leukemia and Abboud, Camille and Berman, Ellin and Cohen, Adam and Cortes, Jorge and DeAngelo, Daniel and Deininger, Michael and Devine, Steven and Druker, Brian and Fathi, Amir and Jabbour, Elias and Jagasia, Madan and Kantarjian, Hagop and Khoury, Jean and Laneuville, Pierre and Larson, Richard and Lipton, Jeffrey and Moore, Joseph O and Mughal, Tariq and O'Brien, Susan and Pinilla-Ibarz, Javier and Quintas-Cardama, Alfonso and Radich, Jerald and Reddy, Vishnu and Schiffer, Charles and Shah, Neil and Shami, Paul and Silver, Richard T and Snyder, David and Stone, Richard and Talpaz, Moshe and Tefferi, Ayalew and Van Etten, Richard A and Wetzler, Meir and Abruzzese, Elisabetta and Apperley, Jane and Breccia, Massimo and Byrne, Jenny and Cervantes, Francisco and Chelysheva, Ekaterina and Clark, R.E and De Lavallade, Hugues and Dyagil, Iryna and Gambacorti-Passerini, Carlo and Goldman, John and Haznedaroglu, Ibrahim and Hjorth-Hansen, Henrik and Holyoake, Tessa and Huntly, Brian and Le Coutre, Philipp and Lomaia, Elza and Mahon, Francois-Xavier and Marin-Costa, David and Martinelli, Giovanni and Mayer, Jiri and Milojkovic, Dragana and Olavarria, Eduardo and Porkka, Kimmo and Richter, Johan and Rousselot, Philippe and Saglio, Giuseppe and Saydam, Guray and Stentoft, Jesper and Turkina, Anna and Vigneri, Paolo and Zaritskey, Andrey and Aguayo, Alvaro and Ayala, Manuel and Bendit, Israel and Bengio, Raquel Maria and Best, Carlos and Bullorsky, Eduardo and Cervera, Eduardo and Desouza, Carmino and Fanilla, Ernesto and Gomez-Almaguer, David and Hamerschlak, Nelson and Lopez, Jose and Magarinos, Alicia and Meillon, Luis and Milone, Jorge and Moiraghi, Beatriz and Pasquini, Ricardo and Pavlovsky, Carolina and Ruiz-Arguelles, Guillermo J and Spector, Nelson and Arthur, Christopher and Browett, Peter and Grigg, Andrew and Hu, Jianda and Huang, Xiao-jun and Hughes, Tim and Jiang, Qian and Jootar, Saengsuree and Kim, Dong-Wook and Malhotra, Hemant and Malhotra, Pankaj and Matsumura, Itaru and Melo, Junia and Ohnishi, Kazunori and ... and Experts Chronic Myeloid Leukemia and Experts in Chronic Myeloid Leukemia
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 22, pp. 4439 - 4442
Journal Article
Journal Article
Venture Capital, ISSN 1369-1066, 07/2019, Volume 21, Issue 2-3, pp. 195 - 221
We empirically explore the importance of networks in the match formation of startups and investors. Using a massive network of connections from the... 
matching game | startups | networks | investors | sorting | Entrepreneurial Finance | Entrepreneurial finance | Startups | Investors
Journal Article